Kalaris Therapeutics Inc (KLRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,183 | -168,710 | -130,574 | -88,502 | -43,863 |
| Depreciation Amortization | 86 | 723 | 637 | 552 | 466 |
| Accounts receivable | -87 | -107 | -211 | -41 | -122 |
| Accounts payable and accrued liabilities | -486 | -12,622 | -10,886 | -10,365 | -13,786 |
| Other Working Capital | -782 | -16,146 | -13,445 | -9,591 | -14,002 |
| Other Operating Activity | 10,334 | 54,810 | 43,998 | 32,593 | 24,831 |
| Operating Cash Flow | $-32,118 | $-142,052 | $-110,481 | $-75,354 | $-46,476 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 41,724 | -80,478 | -94,015 | -55,458 | -54,979 |
| Investing Cash Flow | $41,724 | $-80,478 | $-94,015 | $-55,458 | $-54,979 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 126,961 | 126,669 | 244 | N/A |
| Financing Cash Flow | $N/A | $126,961 | $126,669 | $244 | $N/A |
| Beginning Cash Position | 106,944 | 202,513 | 202,513 | 202,513 | 202,513 |
| End Cash Position | 116,550 | 106,944 | 124,686 | 71,945 | 101,058 |
| Net Cash Flow | $9,606 | $-95,569 | $-77,827 | $-130,568 | $-101,455 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,118 | -142,052 | -110,481 | -75,354 | -46,476 |
| Free Cash Flow | -32,118 | -142,052 | -110,481 | -75,354 | -46,476 |